Acadia Healthcare Basic EPS 2010-2024 | ACHC
Acadia Healthcare basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Acadia Healthcare Annual Basic EPS |
| 2023 |
$-0.24 |
| 2022 |
$3.05 |
| 2021 |
$2.15 |
| 2020 |
$-7.65 |
| 2019 |
$1.24 |
| 2018 |
$-2.01 |
| 2017 |
$2.30 |
| 2016 |
$0.07 |
| 2015 |
$1.65 |
| 2014 |
$1.51 |
| 2013 |
$0.85 |
| 2012 |
$0.53 |
| 2011 |
$-1.86 |
| 2010 |
$0.35 |
| 2009 |
$0.16 |
| Acadia Healthcare Quarterly Basic EPS |
| 2024-09-30 |
$0.74 |
| 2024-06-30 |
$0.86 |
| 2024-03-31 |
$0.84 |
| 2023-12-31 |
$0.63 |
| 2023-09-30 |
$-2.39 |
| 2023-06-30 |
$0.79 |
| 2023-03-31 |
$0.73 |
| 2022-12-31 |
$0.69 |
| 2022-09-30 |
$0.79 |
| 2022-06-30 |
$0.89 |
| 2022-03-31 |
$0.68 |
| 2021-12-31 |
$0.80 |
| 2021-09-30 |
$0.74 |
| 2021-06-30 |
$0.50 |
| 2021-03-31 |
$0.11 |
| 2020-12-31 |
$-8.91 |
| 2020-09-30 |
$0.42 |
| 2020-06-30 |
$0.47 |
| 2020-03-31 |
$0.38 |
| 2019-12-31 |
$-0.14 |
| 2019-09-30 |
$0.49 |
| 2019-06-30 |
$0.55 |
| 2019-03-31 |
$0.34 |
| 2018-12-31 |
$-3.79 |
| 2018-09-30 |
$0.53 |
| 2018-06-30 |
$0.67 |
| 2018-03-31 |
$0.58 |
| 2017-12-31 |
$0.81 |
| 2017-09-30 |
$0.52 |
| 2017-06-30 |
$0.57 |
| 2017-03-31 |
$0.40 |
| 2016-12-31 |
$0.47 |
| 2016-09-30 |
$-1.36 |
| 2016-06-30 |
$0.65 |
| 2016-03-31 |
$0.31 |
| 2015-12-31 |
$0.50 |
| 2015-09-30 |
$0.42 |
| 2015-06-30 |
$0.50 |
| 2015-03-31 |
$0.23 |
| 2014-12-31 |
$0.39 |
| 2014-09-30 |
$0.43 |
| 2014-06-30 |
$0.43 |
| 2014-03-31 |
$0.26 |
| 2013-12-31 |
$0.25 |
| 2013-09-30 |
$0.29 |
| 2013-06-30 |
$0.24 |
| 2013-03-31 |
$0.07 |
| 2012-12-31 |
$0.11 |
| 2012-09-30 |
$0.15 |
| 2012-06-30 |
$0.16 |
| 2012-03-31 |
$0.11 |
| 2011-12-31 |
$-0.79 |
| 2011-09-30 |
$0.18 |
| 2011-06-30 |
$-1.24 |
| 2011-03-31 |
$-0.01 |
| 2010-12-31 |
|
| 2010-09-30 |
$0.09 |
| 2009-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Hospitals |
$3.551B |
$2.929B |
|
Acadia Healthcare Company, Inc. provides behavioral health care services in the United States. The U.S. segment comprises acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, outpatient community-based services, wholly-owned facility, and also comprehensive treatment centers (CTCs). For the services rendered in its facilities, the company receives payments from (i) state governments under their respective Medicaid and other programs; (ii) commercial insurers; (iii) the federal government under the Medicare program administered by CMS; (iv) public funded sources in the U.K.; and (v) individual patients and clients.
|
